BD Phoenix meropenem-vaborbactam panel

Tuesday, 10 April, 2018 | Supplied by: BD



BD has introduced the ability to execute in vitro rapid identification (ID) and antimicrobial susceptibility testing (AST) for meropenem-vaborbactam in its latest panel for the BD Phoenix Automated Microbiology System, which detects resistance in Enterobacteriaceae, Non-Enterobacteriaceae and most gram-positive bacteria isolates from pure culture belonging to the genera Staphylococcus, Enterococcus and Streptococcus.

The BD Phoenix offers clinical microbiology laboratories the ability to rapidly test antimicrobial resistances or susceptibilities. The company’s rapid results for ID and AST are powered through an oxidation-reduction indicator with turbidity measurement for growth detection, as well as full on-panel antimicrobial concentrations and the BDXpert system for data analysis.

Online: www.bd.com
Phone: 02 8875 7000
Related Products

Abcam engineered knockout cell lysates

Abcam's engineered knockout cell lysates enable proteomic studies by providing researchers...

3M Petrifilm Plates and Plate Reader

The 3M Petrifilm Plates and Plate Reader are designed to distil the complexity, variability and...

3M Molecular Detection System

The 3M Molecular Detection System is designed to help save time and labour with its ready-to-use...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd